Cytokeratin-positive cells in bone marrow for identifying distant micrometastasis of gastric cancer

British Journal of Cancer

Volumn 73, Issue 1, 1996, Pages 83-87

  Maehara, Y ^a   Yamamoto, M ^b   Oda, S ^b   Baba, H ^b   Kusumoto, T ^b   Ohno, S ^a   Ichiyoshi, Y ^a   Sugimachi, K ^a  

^a KYUSHU UNIVERSITY   (Japan)

^b KYUSHU UNIVERSITY HOSPITAL   (Japan)

Author keywords

Bone marrow; Cytokeratin; Gastric cancer; Micrometastasis

Indexed keywords

CYTOKERATIN; MONOCLONAL ANTIBODY;

ARTICLE; BONE MARROW METASTASIS; CANCER INVASION; CELL PROLIFERATION; CLINICAL ARTICLE; CYTOPLASM; EPITHELIUM CELL; HUMAN; HUMAN TISSUE; INTERMEDIATE FILAMENT; PRIORITY JOURNAL; STOMACH CANCER; TUMOR SUPPRESSOR GENE;

EID: 0030029628     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/bjc.1996.15     Document Type: Article

References (28)

1. CATTORETTI G, BECKER MHG, KEY G, DUCHROW M, SCHLÜTER C, GALLE J AND GERDES J. (1992). Monoclonal antibodies against recombinant parts of the Ki-67 antigen (MIB1 and MIB3) detect proliferating cells in microwave-processed formalin-fixed paraffin sections. J. Pathol., 168, 357-363.
2. COTE RJ, ROSEN PP, LESSER ML, OLD LJ AND OSBORNE MP. (1991). Prediction of early relapse in patients with operable breast cancer by detection of occult bone marrow micrometastases. J. Clin. Oncol., 9, 1749-1756.
3. DEBUS E, MOLL R, KRANKE WW, WEBER K AND OSBORN M. (1984). Immunohistochemical distinction of human carcinomas by cytokeratin typing with monoclonal antibodies. Am. J. Pathol., 114, 121-130.
4. DIXON WJ. (ed). (1988). BMDP Statistical Software. University of California Press: Berkeley.
5. GUESDON J-L, TERNYNCK T AND AVRAMEAS S. (1979). The use of avidin biotin interaction in immunoenzymatic techniques. J Histochem. Cytochem., 27, 1131-1139.
6. ICHIYOSHI Y, TODA T, MINAMISONO Y, NAGASAKI S, YAKEISHI Y AND SUGIMACHI K. (1990). Recurrence in early gastric cancer. Surgery, 107, 489-495.
7. JAPANESE RESEARCH SOCIETY EOR GASTRIC CANCER. (1981a). The general rules for the gastric cancer study in surgery and pathology. Part I. Clinical Classification. Jpn. J. Surg., 11, 127-139.
8. JAPANESE RESEARCH SOCIETY FOR GASTRIC CANCER. (1981b). The general rules for the gastric cancer study in surgery and pathology. Part II. Histological classificatioin of gastric cancer. Jpn. J. Surg., 11, 140-145.
9. JAPANESE RESEARCH SOCIETY FOR GASTRIC CANCER. (1993). The General Rules for Gastric Cancer Study. 12th edn. (in Japanese). Kanehara and Company: Tokyo.
10. JOYPAUL BV, HOPWOOD D, NEWMAN EL, QURESHI S, GRANT A, OGSTON SA, LANE DP AND CUSCHIERI A. (1994). The prognostic significance of the accumulation of p53 tumour-suppressor gene protein in gastric adenocarcinoma. Br. J. Cancer, 69, 943-946.
11. KAKEJI Y, KORENAGA D, TSUJITANI S, BABA H, ANAI H, MAEHARA Y AND SUGIMACHI K. (1993). Gastric cancer with p53 overexpression has high potential for metastasising to lymph nodes. Br. J. Cancer, 67, 589-593.
12. KOGA S, TAKEBAYASHI M, KAIBARA N, NISHIDOI H, KIMURA O, KAWASUMI H AND MAKINO M. (1987). Pathological characteristics of gastric cancer that develop hematogenous recurrence, with special reference to the site of recurrence. J. Surg. Oncol., 36, 239-242.
13. KORENAGA D, SAITO A, BABA H, WATANABE A, OKAMURA T, MAEHARA Y AND SUGIMACHI K. (1990). Cytophotometrically determined DNA content, mitotic activity, and lymph node metastasis in clinical gastric cancer. Surgery, 107, 262-267.
14. LAUWERS GY, WAHL SJ, MELAMED J AND ROJAS-CORONA RR. (1993). p53 expression in precancerous gastric lesions: An immunohistochemical study of PAb 1801 monoclonal antibody on adenomatous and hyperplastic gastric polyps. Am. J. Gastroenterol., 88, 1916-1919.
15. LINDEMANN F, SCHLIMOK G, DIRSCHEDL P, WITTE J AND RIETHMÜLLER G. (1992). Prognostic significance of micrometastatic tumour cells in bone marrow of colorectal cancer patients. Lancet, 340, 685-689.
16. MAEHARA Y, MORIGUCHI S, KAKEJI Y, KOHNOE S, KORENAGA D. HARAGUCHI M AND SUGIMACHI K. (1991). Pertinent risk factors and gastric carcinoma with synchronous peritoneal dissemination or liver metastasis. Surgery, 110, 820-823.
17. MAEHARA Y, OKUYAMA T, MORIGUCHI S, ORITA H, KUSUMOTO H, KORENAGA D AND SUGIMACHI K. (1992). Prophylactic lymph node dissection in patients with advanced gastric cancer promotes increased survival time. Cancer, 70, 392-395.
18. MAEHARA Y, BABA H, OHNO S AND SUGIMACHI K. (1995). Cytokeratin staining reveals micrometastasis in lymph nodes of early gastric cancer. Surgery, 117, 480.
19. MANSI JL, BERGER U, EASTON D, MCDONNELL T, REDDING WH, GAZET J-C, MCKINNA A, POWLES TJ AND COOMBES RC. (1987). Micrometastases in bone marrow in patients with primary breast cancer: evaluation as an early predictor of bone metastases. Br. Med. J., 295, 1093-1096.
20. MIZUTANI T, ONDA M, TOKUNAGA A, YAMANAKA N AND SUGISAKI Y. (1993). Relationship of C-erbB-2 protein expression and gene amplification to invasion and metastasis in human gastric cancer. Cancer, 72, 2083-2088.
21. MORIGUCHI S, MAEHARA Y, KORENAGA D, SUGIMACHI K AND NOSE Y. (1992). Risk factors which predict pattern of recurrence after curative surgery for patients with advanced gastric cancer. Surg. Oncol., 1, 341-346.
22. OBERNEDER R, RIESENBERG R, KRIEGMAIR M, BITZER U, KLAMMERT R, SCHNEEDE P, HOFSTETTER A, RIETHMÜLLER G AND PANTEL K. (1994). Immunocytochemical detection and phenotypic characterization of micrometastatic tumour cells in bone marrow of patients with prostate cancer. Urol. Res., 22, 3-8.
23. PANTEL K, IZBICKI JR, ANGSTWURM M, BRAUN S, PASSLICK B, KARG O, THETTER O AND RIETHMÜLLER G. (1993a). Immunocytological detection of bone marrow micrometastasis in operable non-small cell lung cancer. Cancer Res., 53, 1027-1031.
24. PANTEL K, BRAUN S, SCHLIMOK G AND RIETHMÜLLER G. (1993b). Micrometastatic tumour cells in bone marrow in colorectal cancer. Lancet, 341, 501.
25. RICHARD JC, ROSEN PP, LESSER ML, OLD LJ AND OSBORNE MP. (1991). Prediction of early relapse in patients with operable breast cancer by detection of occult bone marrow micrometastases. J. Clin. Oncol., 9, 1749-1756.
26. SCHLIMOK G AND RIETHMÜLLER G. (1990a). Detection, characterization and tumorigenicity of disseminated tumor cells in human bone marrow. Semin. Cancer Biol., 1, 207-215.
27. SCHLIMOK G, FUNKE I, BOCK B, SCHWEIBERER B, WITTE J AND RIETHMULLER G. (1990b). Epithelial tumour cells in bone marrow of patients with colorectal cancer: Immunocytochemical detection, phenotypic characterization, and prognostic significance. J. Clin. Oncol., 8, 831-837.
28. YONEMURA Y, NINOMIYA I, TSUGAWA K, SUGIYAMA K, FUJIMURA T, HIRONO Y, TAKAMURA H, MIYAZAKI I, ENDOU Y, TANAKA M AND SASAKI T. (1993). Correlation between altered expression of retinoblastoma protein and clinical outcome in patients with gastric cancer. Int. J. Oncol., 3, 71-75.